MRX250516P35000
- 0.10
- -0.98-90.74%
Marex Group Newsroom
Piper Sandler Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $44
Barclays Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $44
Marex Group Is Maintained at Overweight by Barclays
KBW Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $45
Barclays Maintains Marex Group(MRX.US) With Buy Rating, Maintains Target Price $43
Citi Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $50
Marex Group Analyst Ratings
Goldman Sachs Maintains Buy on Marex Group, Raises Price Target to $44
KBW Sticks to Its Buy Rating for Marex Group Plc (MRX)
Barclays Maintains Marex Group(MRX.US) With Buy Rating, Maintains Target Price $43
Analysts Are Bullish on Top NA Stocks: Marex Group Plc (MRX), American Healthcare REIT, Inc. (AHR)
Jefferies Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $42
HSBC Downgrades Marex Group to Hold From Buy, Adjusts Price Target to $36 From $33
Marex Group Plc: Strong Performance but Valuation Concerns Justify Hold Rating
Barclays Initiates Marex Group(MRX.US) With Buy Rating, Announces Target Price $43
Citi Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $45
Marex Group Price Target Raised to $40.00/Share From $36.00 by Goldman Sachs
Goldman Sachs Maintains Marex Group(MRX.US) With Buy Rating, Raises Target Price to $40
Barclays Maintains Overweight on Marex Group, Raises Price Target to $43
Marex Group Analyst Ratings